tiprankstipranks
Trending News
More News >
Edwards Lifesciences (EW)
NYSE:EW
US Market
Advertisement

Edwards Lifesciences (EW) Ratios

Compare
1,900 Followers

Edwards Lifesciences Ratios

EW's free cash flow for Q2 2025 was $0.78. For the 2025 fiscal year, EW's free cash flow was decreased by $ and operating cash flow was $0.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.68 3.38 3.03 3.08 3.46
Quick Ratio
3.87 2.40 2.17 2.38 2.56
Cash Ratio
2.33 0.96 0.75 0.84 1.32
Solvency Ratio
1.48 0.59 0.68 0.62 0.36
Operating Cash Flow Ratio
0.57 0.75 1.19 1.68 1.18
Short-Term Operating Cash Flow Coverage
30.69 0.00 47.77 67.93 38.76
Net Current Asset Value
$ 3.69B$ 1.39B$ 610.00M$ 514.00M$ 428.20M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.07 0.08 0.08 0.10
Debt-to-Equity Ratio
0.07 0.10 0.12 0.12 0.15
Debt-to-Capital Ratio
0.06 0.09 0.11 0.11 0.13
Long-Term Debt-to-Capital Ratio
0.06 0.08 0.09 0.09 0.12
Financial Leverage Ratio
1.28 1.41 1.43 1.46 1.58
Debt Service Coverage Ratio
58.70 89.14 38.36 38.52 22.81
Interest Coverage Ratio
0.00 87.16 91.07 73.29 103.06
Debt to Market Cap
0.02 0.01 0.01 <0.01 0.01
Interest Debt Per Share
1.20 1.17 1.15 1.14 1.14
Net Debt to EBITDA
-1.48 -0.25 -0.04 -0.09 -0.45
Profitability Margins
Gross Profit Margin
78.84%77.02%79.93%76.13%75.36%
EBIT Margin
28.62%26.91%33.32%33.00%21.41%
EBITDA Margin
30.62%29.44%36.42%36.12%24.49%
Operating Profit Margin
26.19%25.55%32.49%25.77%37.12%
Pretax Profit Margin
28.62%26.61%32.84%32.53%20.90%
Net Profit Margin
72.96%23.35%28.28%28.73%18.77%
Continuous Operations Profit Margin
24.74%23.30%28.28%28.73%18.77%
Net Income Per EBT
254.92%87.75%86.11%88.31%89.82%
EBT Per EBIT
109.28%104.17%101.08%126.21%56.29%
Return on Assets (ROA)
30.75%14.98%18.35%17.68%11.38%
Return on Equity (ROE)
41.25%21.09%26.21%25.76%18.00%
Return on Capital Employed (ROCE)
12.32%18.78%24.05%18.05%25.67%
Return on Invested Capital (ROIC)
10.63%16.40%20.57%15.83%22.86%
Return on Tangible Assets
39.35%18.26%22.24%21.44%14.36%
Earnings Yield
9.02%3.03%3.30%1.86%1.45%
Efficiency Ratios
Receivables Turnover
6.30 7.25 7.70 7.87 7.28
Payables Turnover
7.40 6.85 5.35 6.11 5.50
Inventory Turnover
1.05 1.18 1.23 1.72 1.35
Fixed Asset Turnover
3.11 3.26 3.12 3.19 2.95
Asset Turnover
0.42 0.64 0.65 0.62 0.61
Working Capital Turnover Ratio
1.14 2.44 2.55 2.41 2.05
Cash Conversion Cycle
356.09 306.08 274.98 199.00 254.79
Days of Sales Outstanding
57.95 50.34 47.41 46.38 50.16
Days of Inventory Outstanding
347.47 309.03 295.78 212.38 271.00
Days of Payables Outstanding
49.33 53.28 68.21 59.77 66.37
Operating Cycle
405.42 359.36 343.19 258.76 321.16
Cash Flow Ratios
Operating Cash Flow Per Share
1.35 1.48 1.97 2.78 1.69
Free Cash Flow Per Share
1.04 1.04 1.54 2.25 1.04
CapEx Per Share
0.32 0.44 0.43 0.53 0.65
Free Cash Flow to Operating Cash Flow
0.76 0.70 0.78 0.81 0.61
Dividend Paid and CapEx Coverage Ratio
4.25 3.36 4.60 5.25 2.59
Capital Expenditure Coverage Ratio
4.25 3.36 4.60 5.25 2.59
Operating Cash Flow Coverage Ratio
1.13 1.29 1.76 2.51 1.52
Operating Cash Flow to Sales Ratio
0.14 0.15 0.23 0.33 0.24
Free Cash Flow Yield
1.32%1.36%2.06%1.74%1.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.08 32.99 30.35 53.72 68.98
Price-to-Sales (P/S) Ratio
8.09 7.70 8.58 15.43 12.95
Price-to-Book (P/B) Ratio
4.36 6.96 7.95 13.84 12.42
Price-to-Free Cash Flow (P/FCF) Ratio
75.62 73.49 48.44 57.58 87.79
Price-to-Operating Cash Flow Ratio
57.82 51.64 37.91 46.62 53.87
Price-to-Earnings Growth (PEG) Ratio
-19.42 -5.41 14.63 0.65 -3.22
Price-to-Fair Value
4.36 6.96 7.95 13.84 12.42
Enterprise Value Multiple
24.93 25.92 23.52 42.63 52.42
Enterprise Value
43.40B 45.81B 46.11B 80.58B 56.31B
EV to EBITDA
24.93 25.92 23.52 42.63 52.42
EV to Sales
7.63 7.63 8.57 15.40 12.84
EV to Free Cash Flow
71.39 72.77 48.36 57.46 87.03
EV to Operating Cash Flow
54.60 51.14 37.85 46.52 53.41
Tangible Book Value Per Share
13.04 8.30 7.04 6.97 4.93
Shareholders’ Equity Per Share
17.96 10.96 9.38 9.36 7.35
Tax and Other Ratios
Effective Tax Rate
0.14 0.12 0.14 0.12 0.10
Revenue Per Share
9.69 9.90 8.70 8.39 7.05
Net Income Per Share
7.07 2.31 2.46 2.41 1.32
Tax Burden
2.55 0.88 0.86 0.88 0.90
Interest Burden
1.00 0.99 0.99 0.99 0.98
Research & Development to Revenue
0.19 0.18 0.18 0.17 0.17
SG&A to Revenue
0.00 0.30 0.29 0.29 0.00
Stock-Based Compensation to Revenue
0.03 0.02 0.02 0.02 0.02
Income Quality
0.19 0.64 0.80 1.15 1.28
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis